Literature DB >> 32526454

Oxygen homeostasis and cardiovascular disease: A role for HIF?

Xinyu Li1, Quyan Zhang1, M I Nasser2, Linyong Xu3, Xueyan Zhang1, Ping Zhu4, Qingnan He5, Mingyi Zhao6.   

Abstract

Hypoxia, the decline of tissue oxygen stress, plays a role in mediating cellular processes. Cardiovascular disease, relatively widespread with increased mortality, is closely correlated with oxygen homeostasis regulation. Besides, hypoxia-inducible factor-1(HIF-1) is reported to be a crucial component in regulating systemic hypoxia-induced physiological and pathological modifications like oxidative stress, damage, angiogenesis, vascular remodeling, inflammatory reaction, and metabolic remodeling. In addition, HIF1 controls the movement, proliferation, apoptosis, differentiation and activity of numerous core cells, such as cardiomyocytes, endothelial cells (ECs), smooth muscle cells (SMCs), and macrophages. Here we review the molecular regulation of HIF-1 in cardiovascular diseases, intended to improve therapeutic approaches for clinical diagnoses. Better knowledge of the oxygen balance control and the signal mechanisms involved is important to advance the development of hypoxia-related diseases.
Copyright © 2020 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Blood vessels; Cardiovascular diseases; Hypoxia-Inducible factor 1; Macrophages; Myocardial infarction

Mesh:

Substances:

Year:  2020        PMID: 32526454     DOI: 10.1016/j.biopha.2020.110338

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  CYP2J2 promotes the development of hepatocellular carcinoma by increasing the EETs production to improve HIF-1α stability.

Authors:  Liang Gui; Qiang Xu; Juju Huang; Gaojue Wu; Hong Tang; Li Hui; Ping Hua; Lili Zhang; Yingwei Zhu
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 2.  Hypoxia signaling in human health and diseases: implications and prospects for therapeutics.

Authors:  Zhen Luo; Mingfu Tian; Ge Yang; Qiaoru Tan; Yubing Chen; Geng Li; Qiwei Zhang; Yongkui Li; Pin Wan; Jianguo Wu
Journal:  Signal Transduct Target Ther       Date:  2022-07-07

3.  Exploring the Potential Mechanism of Shennao Fuyuan Tang for Ischemic Stroke Based on Network Pharmacology and Molecular Docking.

Authors:  Jia Min Li; Zhen Ni Mu; Tian Tian Zhang; Xin Li; Yan Shang; Guo Heng Hu
Journal:  Evid Based Complement Alternat Med       Date:  2021-09-23       Impact factor: 2.629

4.  Cross-Talk Between Nitrosative Stress, Inflammation and Hypoxia-Inducible Factor in Patients with Adrenal Masses.

Authors:  Barbara Choromańska; Piotr Myśliwiec; Tomasz Kozłowski; Magdalena Łuba; Piotr Wojskowicz; Jacek Dadan; Hanna Myśliwiec; Katarzyna Choromańska; Katarzyna Makarewicz; Anna Zalewska; Mateusz Maciejczyk
Journal:  J Inflamm Res       Date:  2021-11-30

Review 5.  Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage.

Authors:  Ahmad Syukri; Mochammad Hatta; Muzakkir Amir; Mohammad Saifur Rohman; Idar Mappangara; Cahyono Kaelan; Siti Wahyuni; Agussalim Bukhari; Ade Rifka Junita; Muhammad Reza Primaguna; Ressy Dwiyanti; Andini Febrianti
Journal:  Ann Med Surg (Lond)       Date:  2022-03-21

6.  Investigation of the pharmacological effect and mechanism of mountain-cultivated ginseng and garden ginseng in cardiovascular diseases based on network pharmacology and zebrafish experiments.

Authors:  Ting Yu; Yan-Xin Zhang; Xin-Juan Liu; Dan-Qing Chen; Dan-Dan Wang; Guo-Qin Zhu; Qi Gao
Journal:  Front Pharmacol       Date:  2022-09-01       Impact factor: 5.988

7.  Immunosuppressive tumor microenvironment in extraskeletal myxoid chondrosarcoma: A case of pleural metastases.

Authors:  Ryosuke Ogata; Hiroshi Soda; Hiroaki Senju; Masaki Fujioka; Midori Shimada; Koki Yamashita; Satoshi Irifune; Ryuta Tagawa; Yosuke Dotsu; Keisuke Iwasaki; Hirokazu Taniguchi; Shinnosuke Takemoto; Yuichi Fukuda; Hiroshi Mukae
Journal:  Thorac Cancer       Date:  2022-08-16       Impact factor: 3.223

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.